среда, 15 июня 2016 г.

Infinity Pharmaceuticals Inc. (INFI) Upgraded to "Neutral" by Wedbush

Infinity Pharmaceuticals Inc. (INFI) Upgraded to "Neutral" by Wedbush


Wedbush currently has $1.50 price target on the stock, down from their prior price target of $3.00. Infinity Pharmaceuticals opened at 1.36 on Tuesday.



from Biotech News